Bridgepoint Group plc (LON:BPT – Get Free Report)’s stock price dropped 11.6% during trading on Tuesday . The company traded as low as GBX 247.20 ($3.21) and last traded at GBX 247.80 ($3.22). Approximately 97,968,586 shares changed hands during mid-day trading, an increase of 1,929% from the average daily volume of 4,828,735 shares. The stock had previously closed at GBX 280.40 ($3.64).
Analyst Ratings Changes
Separately, Citigroup upgraded Bridgepoint Group to a “buy” rating and set a GBX 410 ($5.32) target price for the company in a research report on Thursday, March 20th.
Read Our Latest Stock Report on Bridgepoint Group
Bridgepoint Group Stock Performance
Bridgepoint Group (LON:BPT – Get Free Report) last announced its earnings results on Thursday, March 13th. The company reported GBX 19.50 ($0.25) earnings per share (EPS) for the quarter. Bridgepoint Group had a return on equity of 6.10% and a net margin of 16.74%. On average, sell-side analysts anticipate that Bridgepoint Group plc will post 17.4062165 EPS for the current year.
Bridgepoint Group Dividend Announcement
The firm also recently disclosed a dividend, which will be paid on Thursday, May 22nd. Investors of record on Thursday, April 24th will be issued a dividend of GBX 4.60 ($0.06) per share. This represents a yield of 1.43%. The ex-dividend date is Thursday, April 24th. Bridgepoint Group’s payout ratio is 163.50%.
About Bridgepoint Group
Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct lending and credit opportunities in private credit investments. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.
Featured Stories
- Five stocks we like better than Bridgepoint Group
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Joby Aviation: Operational Momentum vs. Market Sentiment
- What is diluted earnings per share (Diluted EPS)?
- Broadcom’s Big Outperformance Shows Strength Amid Tariff Decline
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Carvana: Can Turnaround Strength Outdrive Market Headwinds?
Receive News & Ratings for Bridgepoint Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bridgepoint Group and related companies with MarketBeat.com's FREE daily email newsletter.